Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown

Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown

Pancreatic cancer reveals the worst prognosis among human cancers with little improvement in its clinical outcome in the last three decades. We previously suggested that polypeptide N-acetylgalactosaminyltransferase 6 (GALNT6), which catalyzes O-type glycosylation of Mucin 1, might be a promising mo...

Full description

Bibliographic Details
Main Authors:	Yunus Emre Tarhan, Taigo Kato, Miran Jang, Yoshimi Haga, Koji Ueda, Yusuke Nakamura, Jae-Hyun Park
Format:	Article
Language:	English
Published:	Elsevier 2016-05-01
Series:	Neoplasia: An International Journal for Oncology Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558616300033

Similar Items

Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells
by: Boya Deng, et al.
Published: (2018-10-01)

Proteomic dataset for altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells
by: Razan Sheta, et al.
Published: (2016-09-01)

Effect of vascular cadherin knockdown on zebrafish vasculature during development.
by: Ian C Mitchell, et al.
Published: (2010-01-01)

Enzymatic comparison and expression pattern of pig B4GALNT2 and B4GALNT2-like proteins
by: Zhang Anjing, et al.
Published: (2023-12-01)

The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
by: Chin-Yap Loh, et al.
Published: (2019-09-01)

Progression of oral squamous cell carcinoma accompanied with reduced E-cadherin expression but not cadherin switch.
by: Takashi Hashimoto, et al.
Published: (2012-01-01)

GALNT3 Maintains the Epithelial State in Trophoblast Stem Cells
by: Deepthi Raghu, et al.
Published: (2019-03-01)

Characterization and expression analysis of Galnts in developing Strongylocentrotus purpuratus embryos.
by: Amber L Famiglietti, et al.
Published: (2017-01-01)

Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarcinoma
by: Qinyuan Jia, et al.
Published: (2024-10-01)

Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells
by: Srikanth Barkeer, et al.
Published: (2018-11-01)

Knockdown of ZFR suppresses cell proliferation and invasion of human pancreatic cancer
by: Xiaolan Zhao, et al.
Published: (2016-05-01)

Knockdown of two Cadherin genes confers resistance to Cry2A and Cry1C in Chilo suppressalis
by: Zan Zhang, et al.
Published: (2017-07-01)

A GALNT3 mutation causing Hyperphosphatemic familial Tumoral calcinosis
by: Aijia Wu, et al.
Published: (2024-09-01)

Hyperphosphatemia With Normal Kidney Function Associated With Genetic Variants of GALNT3
by: Iris Schulz, et al.
Published: (2023-12-01)

Stromal-epithelial interaction induces GALNT14 in prostate carcinoma cells
by: Elena D. Czyrnik, et al.
Published: (2023-08-01)

Evaluation of GALNT16 polymorphisms to breast cancer risk in Chinese population
by: Huangfu Wu, et al.
Published: (2019-08-01)

Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome.
by: Víctor Lorca, et al.
Published: (2017-01-01)

Galnt1 is required for normal heart valve development and cardiac function.
by: E Tian, et al.
Published: (2015-01-01)

Loss of Pancreatic E-Cadherin Causes Pancreatitis-Like Changes and Contributes to CarcinogenesisSummary
by: Yoshihiro Kaneta, et al.
Published: (2020-01-01)

Cadherin switching in oral squamous cell carcinoma: A clinicopathological study
by: Ahmed Noaman Ali, et al.
Published: (2023-07-01)

Knockdown of Radixin Suppresses Gastric Cancer Metastasis In Vitro by Up-Regulation of E-Cadherin via NF-κB/Snail Pathway
by: Yu-Wen Zhu, et al.
Published: (2016-11-01)

O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer
by: Lixia Zhou, et al.
Published: (2022-08-01)

GALNT2 promotes invasiveness of colorectal cancer cells partly through AXL
by: Ying‐Yu Liao, et al.
Published: (2023-01-01)

EFEMP2 Mediates GALNT14-Dependent Breast Cancer Cell Invasion
by: Tao Zuo, et al.
Published: (2018-04-01)

“Switch of E-Cadherin to N-Cadherin expression in different molecular subtypes of breast invasive duct carcinomas and its correlation with clinicopathological features”
by: Mayada S Farrag, et al.
Published: (2021-01-01)

Expression of Concern to: Knockdown of ZFR suppresses cell proliferation and invasion of human pancreatic cancer
by: Xiaolan Zhao, et al.
Published: (2018-06-01)

Functional evaluation of novel variants of B4GALNT1 in a patient with hereditary spastic paraplegia and the general population
by: Kei-ichiro Inamori, et al.
Published: (2024-07-01)

Research progress of GALNT3 as a potential tumor molecular marker and drug target
by: GAO Yixuan, et al.
Published: (2024-11-01)

GalNT2-mediated O-glycosylation affects pancreas development and function in mice
by: Baris Mercanoglu, et al.
Published: (2024-11-01)

B4GALNT3 regulates glycosylation of sclerostin and bone massResearch in context
by: Sofia Movérare-Skrtic, et al.
Published: (2023-05-01)

Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in Colorectal Cancer
by: Makiko Ogawa, et al.
Published: (2022-05-01)

Circ-GALNT16 restrains colorectal cancer progression by enhancing the SUMOylation of hnRNPK
by: Chaofan Peng, et al.
Published: (2021-08-01)

GALNT2 expression is reduced in patients with Type 2 diabetes: possible role of hyperglycemia.
by: Antonella Marucci, et al.
Published: (2013-01-01)

PAR-3 knockdown enhances adhesion rate of PANC-1 cells via increased expression of integrinαv and E-cadherin.
by: Liora Segal, et al.
Published: (2014-01-01)

E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
by: Michele Sommariva, et al.
Published: (2020-04-01)

Loss of Cadherin-11 in pancreatic ductal adenocarcinoma alters tumor-immune microenvironment
by: Aimy Sebastian, et al.
Published: (2023-10-01)

Knocking down GALNT6 promotes pyroptosis of pancreatic ductal adenocarcinoma cells through NF-κB/NLRP3/GSDMD and GSDME signaling pathway
by: Mengyang Ding, et al.
Published: (2023-02-01)

Knockdown of TGF-β in Pancreatic Cancer Helps Ameliorate Gemcitabine Resistance
by: Xinxing Wang, et al.
Published: (2024-07-01)

MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma
by: Xing Wang, et al.
Published: (2020-02-01)

Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy
by: Sheng Wang, et al.
Published: (2021-03-01)